383 related articles for article (PubMed ID: 36456151)
21. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
[TBL] [Abstract][Full Text] [Related]
22. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
[TBL] [Abstract][Full Text] [Related]
23. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
[TBL] [Abstract][Full Text] [Related]
24. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
Front Immunol; 2022; 13():859323. PubMed ID: 35572597
[TBL] [Abstract][Full Text] [Related]
25. Predicting programmed death-ligand 1 expression level in non-small cell lung cancer using a combination of peritumoral and intratumoral radiomic features on computed tomography.
Shiinoki T; Fujimoto K; Kawazoe Y; Yuasa Y; Kajima M; Manabe Y; Ono T; Hirano T; Matsunaga K; Tanaka H
Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 35051908
[TBL] [Abstract][Full Text] [Related]
26. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
[TBL] [Abstract][Full Text] [Related]
27. Deep learning radiomics model based on PET/CT predicts PD-L1 expression in non-small cell lung cancer.
Li B; Su J; Liu K; Hu C
Eur J Radiol Open; 2024 Jun; 12():100549. PubMed ID: 38304572
[TBL] [Abstract][Full Text] [Related]
28. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.
Khorrami M; Bera K; Thawani R; Rajiah P; Gupta A; Fu P; Linden P; Pennell N; Jacono F; Gilkeson RC; Velcheti V; Madabhushi A
Eur J Cancer; 2021 May; 148():146-158. PubMed ID: 33743483
[TBL] [Abstract][Full Text] [Related]
30. Multiparameter spectral CT-based radiomics in predicting the expression of programmed death ligand 1 in non-small-cell lung cancer.
Zheng XX; Ma YQ; Cui YQ; Dong SS; Chang FX; Zhu DL; Huang G
Clin Radiol; 2024 Apr; 79(4):e511-e523. PubMed ID: 38307814
[TBL] [Abstract][Full Text] [Related]
31. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on
Takada K; Toyokawa G; Okamoto T; Baba S; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Honda H; Oda Y; Maehara Y
Cancer Med; 2017 Nov; 6(11):2552-2561. PubMed ID: 28980429
[TBL] [Abstract][Full Text] [Related]
32. Quantitative CT texture analysis in predicting PD-L1 expression in locally advanced or metastatic NSCLC patients.
Bracci S; Dolciami M; Trobiani C; Izzo A; Pernazza A; D'Amati G; Manganaro L; Ricci P
Radiol Med; 2021 Nov; 126(11):1425-1433. PubMed ID: 34373989
[TBL] [Abstract][Full Text] [Related]
33. Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding.
Khodabakhshi Z; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):713-725. PubMed ID: 37599160
[TBL] [Abstract][Full Text] [Related]
34. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and
Ju H; Kim K; Kim BI; Woo SK
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770
[TBL] [Abstract][Full Text] [Related]
35. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
36. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.
Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268
[TBL] [Abstract][Full Text] [Related]
37. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
Zhang Y; Liu H; Chang C; Yin Y; Wang R
PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892
[TBL] [Abstract][Full Text] [Related]
38. The radiomic biomarker in non-small cell lung cancer:
Wang YB; He X; Song X; Li M; Zhu D; Zhang F; Chen Q; Lu Y; Wang Y
Clin Radiol; 2023 Oct; 78(10):e732-e740. PubMed ID: 37419772
[TBL] [Abstract][Full Text] [Related]
39. [CT-Based Weighted Radiomic Score Predicts Tumor Response to Immunotherapy in Non-Small Cell Lung Cancer].
Zhu ZC; Chen MJ; Song L; Wang JH; Hu G; Han W; Tan WX; Zhou Z; Sui X; Song W; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):794-802. PubMed ID: 37674467
[TBL] [Abstract][Full Text] [Related]
40. Prediction of Tumor PD-L1 Expression in Resectable Non-Small Cell Lung Cancer by Machine Learning Models Based on Clinical and Radiological Features: Performance Comparison With Preoperative Biopsy.
Hashimoto K; Murakami Y; Omura K; Takahashi H; Suzuki R; Yoshioka Y; Oguchi M; Ichinose J; Matsuura Y; Nakao M; Okumura S; Ninomiya H; Nishio M; Mun M
Clin Lung Cancer; 2024 Jan; 25(1):e26-e34.e6. PubMed ID: 37673781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
